Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading 0.3% Higher – Here’s Why

Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) were up 0.3% on Wednesday . The company traded as high as $2.0720 and last traded at $2.0160. Approximately 5,410 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 16,178 shares. The stock had previously closed at $2.01.

Medexus Pharmaceuticals Trading Up 0.3%

The business has a fifty day simple moving average of $1.98 and a 200-day simple moving average of $2.03.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.